|
VOLUME 31: NO. 6 JUNE 2004
Editorials
Is There a Rationale for Switching from One
Anti-TNF Agent to Another?
B. Haraoui .........1021
Rheumatoid Arthritis: Is the Disease Becoming Milder or Is Treatment Improving?
S. Walji, V.P. Bykerk .........1023
Measuring Patient Health Status in RA
What Is a Minimal Clinically Important Difference?
S. Brealey .........1026
What I Would Like to Know About Leflunomide
J.M. Kremer .........1029
Coping with Chronic Pain: What Can We Learn from Pain Self-Efficacy Beliefs?
D. Saunders .........1032
Hypertension, NSAID, and Lessons Learned
J.E. Pope .........1035
Articles
Activation of Synovial Cell p38 MAP Kinase by Macrophage Migration Inhibitory Factor
L.L. Santos, D. Lacey, Y. Yang, M. Leech,
E.F. Morand .........1038
Expression of Tristetraprolin (G0S24) mRNA, a Regulator of TNF-a Production, in Synovial Tissues of Patients with RA
A. Tsutsumi, E. Suzuki, Y. Adachi, et al .........1044
Radiographic Hand Joint Space Width Assessed
by Computer Is a Sensitive Measure of Change in Early RA
J. Angwin, A. Lloyd, G. Heald, G. Nepom, M. Binks, M.F. James .........1050
Variability of Precision in Scoring Radiographic Abnormalities in RA by Experienced Readers
J.T. Sharp, F. Wolfe, M. Lassere, et al .........1062
Radiographic Progression Is Getting Milder in Patients with Early RA. Results of 3 Cohorts Over 5 Years
T. Sokka, H. Kautiainen,
A. Häkkinen, P. Hannonen .........1073
Effects of High Dose Methylprednisolone Pulse Therapy on Bone Mass and Biochemical Markers of Bone Metabolism in Patients with Active RA:
A 12-Month Randomized Prospective Controlled Study
B. Frediani, P. Falsetti, S. Bisogno, et al .........1083
Progression of RA on Plain Radiographs Judged Differently by Expert Radiologists and Rheumatologists
K. Bruynesteyn, S. van der Linden, R. Landewé,
F. Gubler, R. Weijers, D. van der Heijde .........1088
High Sensitivity C-Reactive Protein as a Disease Activity Marker in RA
P.H. Dessein, B.I. Joffe, A.E. Stanwix .........1095
The Efficacy of Switching from Etanercept to Infliximab in Patients with RA
K.E. Hansen, J.P. Hildebrand, M.C. Genovese, et al .........1098
Effects of Anakinra Monotherapy on Joint
Damage in Patients with RA. Extension of a
24-Week Randomized, Placebo-Controlled Trial
B. Bresnihan, R. Newmark, S. Robbins,
H.K. Genant, for the European Group of
Clinical Investigators .........1103
Comparative Study of Serum Surfactant Protein-D and KL-6 Concentrations in Patients with SSc as Markers for Monitoring the Activity of Pulmonary Fibrosis
K. Yanaba, M. Hasegawa, K. Takehara, S. Sato .........1112
Centromere Protein C Is a Target of Autoantibodies
in SS and Is Uniformly Associated with
Antibodies to Ro and La
S.R. Pillemer,
L. Casciola-Rosen, B.J. Baum, A. Rosen,
A.C. Gelber .........1121
The Clinical Assessment of Patients with PsA: Results of a Reliability Study of the Spondyloarthritis Research Consortium of Canada
D.D. Gladman, R.J. Cook, C. Schentag, et al .........1126
Anti-IL-6 Receptor Antibody Inhibits Murine
AA-Amyloidosis
M. Mihara, M. Shiina, N. Nishimoto,
K. Yoshizaki, T. Kishimoto, K-I. Akamatsu .........1132
Influence of Serum Amyloid A (SAA1) and SAA2
Gene Polymorphisms on Renal Amyloidosis,
and on SAA/CRP Values in Patients with Familial Mediterranean Fever in the Turkish Population
A. Bakkaloglu, A. Duzova, S. Ozen, et al .........1139
Blood Pressure Destabilization and Edema Among 8538 Users of Celecoxib, Rofecoxib, and Nonselective NSAID and Nonusers of NSAID Receiving Ordinary Clinical Care
F. Wolfe, S. Zhao, M. Reynolds, D. Pettitt .........1143
Hypertension Was the Major Risk Factor Leading to Development of Cardiovascular Diseases Among Men with Hyperuricemia
K-C. Lin, H-M. Tsao, C-H. Chen, P. Chou .........1152
Different Progressions of Hyperglycemia and Diabetes Among Hyperuricemic Men and Women in the Kinmen Study
K-C. Lin, S-T. Tsai, H-Y. Lin, P. Chou .........1159
The Effect of a Preoperative Exercise and Education Program on Functional Recovery, Health Related Quality of Life, and Health Service Utilization Following Primary Total Knee Arthroplasty
L.A. Beaupre, D. Lier, D.M. Davies, D.W.C. Johnston .........1166
Cartilage Destruction in Collagen Induced Arthritis Assessed with a New Biochemical Marker for Collagen Type II C-Telopeptide Fragments
T. Ishikawa, F. Nishigaki, S. Christgau, et al .........1174
The Comprehensive OA Test: a Simple Index for Measurement of Treatment Effects in Clinical Trials
L.O. Brooks, M.I. Rolfe, P.A. Cheras, S.P. Myers .........1180
Important Determinants of Self-Efficacy in Patients with Chronic Musculoskeletal Pain
A. Rahman,
G. Ambler, M.R. Underwood, M.E. Shipley .........1187
Cyclic Alternating Pattern: A New Marker of Sleep Alteration in Patients with FM?
M. Rizzi, P. Sarzi-Puttini, F. Atzeni, et al .........1193
Physician Resources and Postgraduate Training in Canadian Academic Rheumatology Centers:
A 5-Year Prospective Study
J.G. Hanly, for the
Canadian Council of Academic Rheumatologists .........1200
Pediatric Rheumatology
Association of Single Nucleotide Polymorphisms within Cytokine Genes with JIA in the Czech Population
O. Cinek, P. Vavrincová, I. Striz, et al .........1206
Antiagalactosyl IgG Antibodies in JIA, Juvenile
Onset SS, and Healthy Children
N. Maeno, S. Takei, S. Fujikawa, et al .........1211
Case Reports
Vasopressin Cell Antibodies and Central Diabetes Insipidus in a Patient with SLE and DM
H. Kajiyama, C. Terai, A. De Bellis, et al .........1218
Identity Loss Due to Chronic Fingertip Ischemia
J.C. Crispin, M. Fallena, A. Kraus .........1222
Images in Rheumatology
Diagnosis and Followup of Takayasu's Arteritis by Scintigraphy with Radiolabelled IL-2
P. Lucia, M.G. Parisella, C. Danese, et al .........1225
Letter
Dose-Dependent Severe Arthralgia Induced by Gabapentin A. Almahrezi, M-A. Fitzcharles .........1228
Notices
|